Sentences with phrase «cancer radiotherapy»

Comparative Study between Field - in - Field and IMRT Techniques in Prostate Cancer Radiotherapy: A Treatment Planning Study

Purpose of Study: The overall goal of this project was to develop and investigate a novel functional imaging technique for pulmonary function (gas exchange) based on computed tomography (CT) to increase therapeutic gains of lung cancer radiotherapy.

LA JOLLA, CA — Discovering that mouse hair has a circadian clock — a 24 - hour cycle of growth followed by restorative repair — researchers suspect that hair loss in humans from toxic cancer radiotherapy and chemotherapy might be minimized if these treatments are given late in the day.

A newly NIH funded clinical trial (NCT02528942) by University of Colorado Cancer Center investigators and collaborators at Beaumont Health in Michigan and the University of Texas Medical Branch is evaluating a new method for pinpointing and sparing healthy lung tissue during lung cancer radiotherapy.

The group is applying advanced image analysis techniques to 4D CT scans already performed as a standard step in targeting lung cancer radiotherapy, to map areas of lung function without additional testing.

Soraia Rosa, a Portuguese Ph.D. candidate in cancer radiotherapy research who came to Queen's University Belfast with a Marie Skłodowska - Curie fellowship, also feels that it is too early to be concerned.

«Invisible tattoos» could improve body confidence after breast cancer radiotherapy.»

The Cancer Radiotherapy Innovation Fund, unveiled by Prime Minister David Cameron and Health Secretary Jeremy Hunt, will cover the remainder of 2012 - 13.

Breast Cancer Care comments on NICE recommendation of new breast cancer radiotherapy treatment

Not exact matches

Novartis snatches up cancer «radiotherapy» firm Advanced Accelerator Applications.

As a physics teacher, I teach the therapeutic effects of gamma radiation in radiotherapy, along with the associated dangers (radiation can cause cells to become cancerous as well as kill cells that are already cancerous), but a common misconception among students is that cancer cells are rather like viruses or bacteria, a sort of alien cell that has entered the body, growing out of control with little relation to the surrounding cells.

«Intrabeam radiotherapy is another exciting development and could dramatically improve the quality of life of some women diagnosed with breast cancer, but there is not yet evidence of its long term benefits.

Responding to the announcement from the University of Edinburgh that some older breast cancer patients could safely skip radiotherapy Dr Emma Pennery CBE, Clinical Director at Breast Cancer Care,cancer patients could safely skip radiotherapy Dr Emma Pennery CBE, Clinical Director at Breast Cancer Care,Cancer Care, says:

Breast Cancer Care responds to University of Edinburgh research showing some patients can skip radiotherapy

Radiotherapy is still a highly effective treatment for many women with breast cancer.»

Speaking on the 31st Convocation lecture of the institution titled» Stepping Out Into The World; Potential Well - Being, Change in Lifestyle And Cancer Education», the don lamented the drain the disease cost on the nation's resources through just about five per cent of the cancer patients (10,000) that had resources to go abroad where they pay between $ 10,000 - $ 15,000 per patient for a three to five weeks course of RadiothCancer Education», the don lamented the drain the disease cost on the nation's resources through just about five per cent of the cancer patients (10,000) that had resources to go abroad where they pay between $ 10,000 - $ 15,000 per patient for a three to five weeks course of Radiothcancer patients (10,000) that had resources to go abroad where they pay between $ 10,000 - $ 15,000 per patient for a three to five weeks course of Radiotherapy.

Health Secretary Jeremy Hunt said: «Radiotherapy is one of the most clinically and cost - effective treatments for cancer and this funding will bring our additional investment in radiotherapy over the Spending Review period to # 165 milRadiotherapy is one of the most clinically and cost - effective treatments for cancer and this funding will bring our additional investment in radiotherapy over the Spending Review period to # 165 milradiotherapy over the Spending Review period to # 165 million.»

It is generally agreed that around 50 per cent of cancer patients should receive radiotherapy as part of their treatment.

Health Secretary, Andrew Lansley, unveiling plans to invest up to # 150 million in procuring a new cutting - edge «proton beam therapy» radiotherapy cancer service — December 2011

Approximately one year after successful treatment with cytotoxic chemotherapy and radiotherapy, patients with advanced Small Cell Lung Cancer (SCLC), which primarily affects heavy smokers, generally relapse with recurrence of tumours that are resistant to further chemotherapy.

«Radiotherapy: Novel lung cancer treatment meets with success.»

That means that roughly 36 of the 190 women who received annual mammography for 10 years and were diagnosed with breast cancer would receive unnecessary surgery, chemotherapy or radiotherapy.

A late breaking subanalysis of the phase III CONVERT trial presented at the European Lung Cancer Conference (ELCC) shows that white blood cell boosting drugs are safe during concurrent chemo - radiotherapy of small cell lung cancer (Cancer Conference (ELCC) shows that white blood cell boosting drugs are safe during concurrent chemo - radiotherapy of small cell lung cancer (cancer (SCLC).

In addition, the Danish Breast Cancer Oncology Group also adopted this partial breast radiotherapy technique for selected patients.

It also moves the cancer cells away from the place where they were growing which could allow them to be removed through traditional cancer treatments such as radiotherapy, chemotherapy or surgery.

The researchers at 30 radiotherapy centres across the UK, led by The Institute of Cancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingcancer that was at a low risk of coming back.

Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, and their cancer is just as unlikely to return, according to trial results published in The Lancet.

But down the hallway in the radiation ward, cancer patients typically get a one - size - fits - all course of radiotherapy, regardless of their genetics or those of their cancer.

«Targeted radiotherapy limits side effects of breast cancer treatment.»

The authors had data for 2,679 women (average age 64) with a diagnosis of DCIS between 1990 and 2011 and for 757 women (average age 79) with a DCIS diagnosis between 1991 and 2009 who had not undergone radiotherapy for DCIS and experienced a subsequent breast cancer or DCIS diagnosis.

The NIHR - funded researchers, based at The Royal Marsden hospital in London, asked 42 breast cancer patients undergoing radiotherapy to rate how they felt about their body, before the treatment and one month later.

Chemotherapy and radiotherapy alone are relatively unsuccessful in treating the disease, and while surgery to remove the tumour offers the best chance of survival, most patients are diagnosed when the cancer has already spread to other organs.

The authors report that women who lived in an area with greater radiotherapy with BCS were more likely to undergo mastectomy if they had a second breast cancer even though they were candidates for BCS since they had initially foregone radiotherapy.

Invisible tattoos could replace the permanent dark ink tattoos used to ensure that breast cancer patients having radiotherapy are treated in exactly the same spot during each session, according to results from a pilot study to be presented at the National Cancer Research Institute (NCRI) Cancer Confecancer patients having radiotherapy are treated in exactly the same spot during each session, according to results from a pilot study to be presented at the National Cancer Research Institute (NCRI) Cancer ConfeCancer Research Institute (NCRI) Cancer ConfeCancer Conference.

However, in the largest study of its kind so far, scientists from the German Cancer Research Center (DKFZ) in Heidelberg have now shown that the risk of death from heart disease in breast cancer patients following radiotherapy or chemotherapy is no higher than it is among the average populCancer Research Center (DKFZ) in Heidelberg have now shown that the risk of death from heart disease in breast cancer patients following radiotherapy or chemotherapy is no higher than it is among the average populcancer patients following radiotherapy or chemotherapy is no higher than it is among the average population.

«However, a number of clinical trials have suggested that both chemotherapy and radiotherapy are associated with the risk of suffering heart disease as a consequence of treatment,» says Hermann Brenner from the German Cancer Research Center (DKFZ) in Heidelberg.

Liang Xu, Ph.D. member of the KU Cancer Center's Drug Discovery, Delivery and Experimental Therapeutics program and associate professor of molecular biosciences at KU, has discovered that targeting a cell - surface receptor called «CD44s» can block pancreatic tumor formation and recurrence after radiotherapy.

In nuclear medicine, ion beams — using protons and carbon ions — have been used clinically in the radiotherapy treatment of cancer tumours since the 1990s.

As part of the project, announced last week by Kenneth Hagemann, director of the Pentagon's Defense Nuclear Agency, 24 soldiers from Brooks Air Force Base in Texas are taking prescription drugs — ondansetron hydrochloride and granisetron hydrochloride — that are given to cancer patients undergoing radiotherapy or chemotherapy.

«Prostate cancer patients who receive permanent radiotherapy implants twice as likely to be free of cancer after five years.»

Results from a randomised controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose - escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer - free five years later.

The difference in breast cancer - free survival between those receiving and not receiving radiotherapy (98.5 percent vs. 96.4 percent), however, was statistically significant.

However, what our trial has shown is that although this is still the case, the proportion of women who will actually have a recurrence without radiotherapy is very small (less than 5 percent), five years after treatment,» said Ian Kunkler, F.R.C.R., professor of clinical oncology at the Edinburgh Cancer Research Center in the University of Edinburgh.

«Avoiding radiotherapy is an option for some older patients with breast cancer.»

Another important aspect of the green - light KTP laser approach, Zeitels adds, is that biopsy and treatment of patients whose cancer involves a single vocal cord usually can be accomplished in the same procedure, whereas radiotherapy requires a prior biopsy to determine the extent and location of the tumor, followed by daily radiation treatments over approximately six weeks.

Rather, cancer patients — whose eggs might be destroyed by chemotherapy or radiotherapy — will benefit the most if this still - experimental procedure becomes practical.

Omission of radiotherapy is a reasonable option for women age 65 or older who receive hormone therapy after breast - conserving surgery for hormone receptor - positive, axillary node - negative breast cancer, according to results of the PRIME 2 trial presented at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10cancer, according to results of the PRIME 2 trial presented at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10Cancer Symposium, held Dec. 10 - 14.

The first long - term study of a pioneering endoscopic laser treatment for early vocal - cord cancer, developed at Massachusetts General Hospital (MGH) and previously shown to provide optimal voice outcomes, finds that it is as successful as traditional approaches in curing patients» tumors while avoiding the damage to vocal quality caused by radiotherapy or by conventional laser or cold - instrument surgery.

So it is important to preserve the option of radiotherapy for treating future, more substantial cancers, the development of which is not uncommon.»

Cancer stem cells, a type of self - renewing cell found in tumors, are of particular interest because they are the main cell type responsible for tumor progression and for resistance to chemotherapy and radiotherapy, and therefore a major cause of tumor recurrence after treatment.